Nephrology
Conference Coverage
Poorer survival of African Americans with kidney cancer may be due to genomic differences
Key clinical point: The poorer survival of African American patients vs.
News
Proton pump inhibitors linked to chronic kidney disease
The use of proton pump inhibitors increased the risk of chronic kidney disease by 20%-50%, said the authors of two large population-based cohort...
Conference Coverage
Denosumab boosts BMD in kidney transplant recipients
Twice-yearly denosumab effectively increased bone mineral density in kidney transplant recipients, but was associated with more frequent episodes...
News
METEOR: Cabozantinib bests everolimus across renal cancer subgroups
Key clinical point: Cabozantinib appears more efficacious than does everolimus for a wide range of patients. Major finding: Progression-free...
Conference Coverage
In hemodialysis, HDL cholesterol levels steady in men, fall in women
Among incident hemodialysis patients, HDL cholesterol levels remain stable over time in men, but mildly decrease over time in women, regardless of...
Conference Coverage
Treat high LDL cholesterol in CKD, even with inflammation
LDL cholesterol level was positively associated with risk of atherosclerotic vascular events in chronic kidney disease.
Conference Coverage
Nalbuphine reduced uremic pruritus in hemodialysis
Oral nalbuphine at 120 mg twice daily provided relief to hemodialysis patients with uremic pruritus.
Conference Coverage
Expert shares ‘recipe’ for kidney stone disease
What factors are driving the rise in kidney stone disease prevalence?
Conference Coverage
Perioperative statins for cardiac surgery didn’t reduce kidney injury
High-dose perioperative statin treatment didn’t reduce acute kidney injury after elective cardiac surgery – and may increase risk in patients with...
Conference Coverage
Hormone treatment associated with better kidney function
The use of hormone therapy was associated with a lower urine albumin-to-creatinine ratio and a decreased risk of albuminuria.
Conference Coverage
Early-stage kidney disease benefits most from intensive glucose control
Key clinical point: The benefit of intensive glucose control in reducing the risk of end-stage kidney disease is greatest when started before...